CASE REPORT: Beneficial Effects of Topical Testosterone Replacement in Patients with End-Stage Liver Disease

被引：0
|
作者：
Guy W. Neff
Christopher B. O'Brien
Marzia Montalbano
Douglas Meyer
Antoinette DeManno
Halim Muslu
Kamran Safdar
Stephanie Kahn
Seigo Nishida
Eugene R. Schiff
机构：
[1] University of Miami,The Center for Liver Diseases, Division of GI Transplant, Departments of Medicine and Surgery
来源：
Digestive Diseases and Sciences | 2004年 / 49卷
关键词：
orthotopic liver transplantation; topical testosterone replacement; end-stage liver disease; muscle wasting; hepatitis C virus;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1186 / 1189
页数：3
相关论文
共 50 条
  • [1] Beneficial effects of topical testosterone replacement in patients with end-stage liver disease
    Neff, GW
    O'Brien, CB
    Montalbano, M
    Meyer, D
    DeManno, A
    Muslu, H
    Safdar, K
    Kahn, S
    Nishida, S
    Schiff, ER
    DIGESTIVE DISEASES AND SCIENCES, 2004, 49 (7-8) : 1186 - 1189
  • [2] Beneficial effects of topical testosterone replacement in patients with end stage liver disease.
    Neff, GW
    Safdar, K
    Karl, M
    O'Brien, C
    Demanno, A
    Kahn, S
    Nery, J
    Meyer, D
    Bueno, T
    Muslu, H
    Nishida, S
    Schiff, ER
    Tzakis, AG
    HEPATOLOGY, 2003, 38 (04) : 376A - 376A
  • [3] Testosterone metabolism and replacement therapy in patients with end-stage renal disease
    Johansen, KL
    SEMINARS IN DIALYSIS, 2004, 17 (03) : 202 - 208
  • [4] Hypogonadism and testosterone replacement therapy in end-stage renal disease (ESRD) and transplant patients
    Snyder, Grace
    Shoskes, Daniel A.
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2016, 5 (06) : 885 - 889
  • [5] Effects of Smoking on Survival for Patients with End-Stage Liver Disease
    Lee, Dennis S.
    Mathur, Amit K.
    Acker, William B., II
    Al-Holou, Shaza N.
    Ehrlichman, Lauren K.
    Lewin, Sarah A.
    Nguyen, Christopher K. B.
    Peterson, Sarah F.
    Ranney, David N.
    Sell, Kristen
    Kubus, James
    Englesbe, Michael J.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2009, 208 (06) : 1077 - 1084
  • [6] Mortality in patients with end-stage liver disease above model for end-stage liver disease 3.0 of 40
    Tarlow, Branden D.
    Kim, W. Ray
    Mannalithara, Ajitha
    Kwo, Paul Y.
    Bonham, C. Andrew
    Kwong, Allison
    HEPATOLOGY, 2023, 77 (03) : 851 - 861
  • [7] NivolumabImmune-mediated liver toxicity and end-stage liver disease: case report
    Reactions Weekly, 2021, 1836 (1) : 595 - 595
  • [8] Prehabilitation for Patients With End-Stage Liver Disease
    Derck, Jordan
    Klemptner, Emilie
    Mazurek, Alyssa
    Fakhoury, Joseph
    Sonnenday, Christopher
    AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15 : 99 - 99
  • [9] Infections in patients with end-stage liver disease
    Cheruvattath, Rekha
    Balan, Vijayan
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2007, 41 (04) : 403 - 411
  • [10] Heart disease in patients with end-stage liver disease
    Colunga Blanco, S.
    Corros Vicente, C.
    Garcia Campos, A.
    Velasco Alonso, E.
    Diaz Pelaez, E.
    Lopez Iglesias, F.
    Martin Fernandez, M.
    De La Hera Galarza, J. M.
    Lambert Rodriguez, J. L.
    Moris De La Tassa, C.
    EUROPEAN JOURNAL OF HEART FAILURE, 2015, 17 : 315 - 315
12345